{"id":329444,"date":"2026-10-28T10:23:35","date_gmt":"2026-10-28T04:53:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=329444"},"modified":"2026-10-28T10:23:35","modified_gmt":"2026-10-28T04:53:35","slug":"midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Stocks Priced Between Rs 1,000 and 2,000 to Watch for Future Multibagger Potential: Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Coforge Rs 1,997. Uno Minda Rs 1,085. Narayana Health Rs 1,713.20. Dr Lal PathLabs Rs 1,901.80. Market caps from Rs 32,408 crore to Rs 90,385 crore. Data as of 27 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs are the 4 picks in this stocks priced between Rs 1,000 and 2,000 watchlist, with market caps between Rs 32,408 crore and Rs 90,385 crore. Coforge stands out for the strongest latest-quarter profit growth at 49.19%, while Uno Minda offers the fastest profit growth, 38.65% a year since FY22. PE ratios run from 42.44 to 59.32, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.<\/p>\n<\/p><\/div>\n<p>Stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs meet that test, with market caps from Rs 32,408 crore to Rs 90,385 crore and Coforge offering the strongest latest-quarter profit growth at 49.19%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price between Rs 1,000 and Rs 2,000, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price between Rs 1,000 and Rs 2,000, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening stocks priced between Rs 1,000 and 2,000 usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=stocks-priced-between-rs-and\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#What_Are_Stocks_Priced_Between_Rs_1000_and_2000_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Stocks Priced Between Rs 1,000 and 2,000 and Why Do They Attract Multibagger Interest?\">What Are Stocks Priced Between Rs 1,000 and 2,000 and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Stocks_Priced_Between_Rs_1000_and_2000_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Stocks Priced Between Rs 1,000 and 2,000 at a Glance: Price, Market Cap, PE and ROE\">Stocks Priced Between Rs 1,000 and 2,000 at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Coforge_2372_Profit_CAGR_Since_FY22\" title=\"Coforge: 23.72% Profit CAGR Since FY22\">Coforge: 23.72% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Uno_Minda_3865_Profit_CAGR_Since_FY22\" title=\"Uno Minda: 38.65% Profit CAGR Since FY22\">Uno Minda: 38.65% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Narayana_Health_2406_Profit_CAGR_Since_FY22\" title=\"Narayana Health: 24.06% Profit CAGR Since FY22\">Narayana Health: 24.06% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Dr_Lal_PathLabs_Return_on_Equity_of_2013\" title=\"Dr Lal PathLabs: Return on Equity of 20.13%\">Dr Lal PathLabs: Return on Equity of 20.13%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Stocks_Priced_Between_Rs_1000_and_2000_Financial_Comparison_on_Growth_and_Margins\" title=\"Stocks Priced Between Rs 1,000 and 2,000: Financial Comparison on Growth and Margins\">Stocks Priced Between Rs 1,000 and 2,000: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Institutional_Holding_in_Coforge_Uno_Minda_Narayana_Health_and_Dr_Lal_PathLabs\" title=\"Institutional Holding in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs\">Institutional Holding in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Stocks_Priced_Between_Rs_1000_and_2000\" title=\"Risks to Weigh in Stocks Priced Between Rs 1,000 and 2,000\">Risks to Weigh in Stocks Priced Between Rs 1,000 and 2,000<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#How_to_Choose_Between_Stocks_Priced_Between_Rs_1000_and_2000\" title=\"How to Choose Between Stocks Priced Between Rs 1,000 and 2,000\">How to Choose Between Stocks Priced Between Rs 1,000 and 2,000<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Stocks_Priced_Between_Rs_1000_and_2000_to_Watch\" title=\"Frequently Asked Questions on Stocks Priced Between Rs 1,000 and 2,000 to Watch\">Frequently Asked Questions on Stocks Priced Between Rs 1,000 and 2,000 to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Which_are_the_best_stocks_priced_between_Rs_1000_and_2000_to_watch_for_multibagger_potential\" title=\"Which are the best stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential?\">Which are the best stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Is_Dr_Lal_PathLabs_a_good_stock_for_long-term_investors\" title=\"Is Dr Lal PathLabs a good stock for long-term investors?\">Is Dr Lal PathLabs a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Can_Uno_Minda_become_a_multibagger_from_here\" title=\"Can Uno Minda become a multibagger from here?\">Can Uno Minda become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Coforge_Uno_Minda_Narayana_Health_and_Dr_Lal_PathLabs\" title=\"What is the market cap of Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?\">What is the market cap of Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_stocks_priced_between_Rs_1000_and_2000\" title=\"What are the risks of investing in stocks priced between Rs 1,000 and 2,000?\">What are the risks of investing in stocks priced between Rs 1,000 and 2,000?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#Why_is_Coforge_trading_at_a_PE_of_4707\" title=\"Why is Coforge trading at a PE of 47.07?\">Why is Coforge trading at a PE of 47.07?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Coforge_Uno_Minda_Narayana_Health_and_Dr_Lal_PathLabs\" title=\"How much do institutions hold in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?\">How much do institutions hold in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Stocks_Priced_Between_Rs_1000_and_2000_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Stocks Priced Between Rs 1,000 and 2,000 and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Stocks priced between Rs 1,000 and 2,000 are shares that trade between Rs 1,000 and Rs 2,000 apiece, a popular price range where many established and fast growing mid sized companies sit. The four here cover IT services, auto components, hospitals and diagnostics.<\/p>\n<p>A mid range share price is easy for retail investors to buy in lots, and when it comes with rising profit it points to a business that keeps building value. Within stocks priced between Rs 1,000 and 2,000, the four companies show rising profit. For stocks priced between Rs 1,000 and 2,000, both FY26 and the latest quarter showed growth. Whichever way you read stocks priced between Rs 1,000 and 2,000, the common thread is rising profit backed by complete financial data. Investors researching stocks priced between Rs 1,000 and 2,000 get a fuller picture by reading growth and valuation together. The table below lines up stocks priced between Rs 1,000 and 2,000 on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use stocks priced between Rs 1,000 and 2,000 as a starting point for your own research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Priced_Between_Rs_1000_and_2000_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Stocks Priced Between Rs 1,000 and 2,000 at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 27 October 2026. Narayana Health has the lowest PE of the group at 42.44, while Dr Lal PathLabs posts the highest return on equity at 20.13%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/coforge\/coforge-ltd-share-price-today\">Coforge<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,997<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">90,385<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">47.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.66<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,008.10 to 2,021.20<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/unominda\/uno-minda-ltd-share-price-today\">Uno Minda<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,085<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">65,032<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">50.38<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">37.22<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">994.00 to 1,355.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\">Narayana Hrudayalaya<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,713.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34,664<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.44<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.76%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1.29<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,589.00 to 2,093.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr Lal PathLabs<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,901.80<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32,408<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,272.60 to 2,038.60<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Coforge_2372_Profit_CAGR_Since_FY22\"><\/span><strong>Coforge: 23.72% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Coforge is an IT services company serving clients in travel, banking, insurance and other industries. It reported FY26 revenue of Rs 16,475.90 crore, up 34.63% year on year, and net profit of Rs 1,674.50 crore, up 73.79%. Net profit has compounded at 23.72% a year since FY22, while revenue has grown 26.26% a year. Operating margin was 17.40% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 49.19% to Rs 5,554.50 crore and net profit grew 49.19% to Rs 531.70 crore. The share price has gained 73.24% over five years and 10.25% over the past year. The stock trades at a PE of 47.07 against an industry PE of 17.66, with a return on equity of 16.31%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Uno_Minda_3865_Profit_CAGR_Since_FY22\"><\/span><strong>Uno Minda: 38.65% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Uno Minda makes switches, lighting, sensors and safety components for two-wheeler, passenger and commercial vehicle makers. It reported FY26 revenue of Rs 19,692.02 crore, up 17.19% year on year, and net profit of Rs 1,284.06 crore, up 25.82%. Net profit has compounded at 38.65% a year since FY22, while revenue has grown 23.83% a year. Operating margin was 12.75% in FY26. The debt-to-equity ratio is 0.40.<\/p>\n<p>The stock trades at a PE of 50.38 against an industry PE of 37.22, with a return on equity of 17.53%. In the June 2026 quarter, revenue rose 23.60% to Rs 5,563.16 crore and net profit grew 2.10% to Rs 315.51 crore. The share price has gained 187.71% over five years. Domestic institutions raised their holding from 15.85% in June 2025 to 17.53% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Health_2406_Profit_CAGR_Since_FY22\"><\/span><strong>Narayana Health: 24.06% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Narayana Health runs a network of multi-speciality hospitals, with a strong cardiac care franchise and a presence in India and the Cayman Islands. It reported FY26 revenue of Rs 7,996.25 crore, up 43.43% year on year, and net profit of Rs 810.46 crore, up 2.61%. Net profit has compounded at 24.06% a year since FY22, while revenue has grown 20.95% a year. Operating margin was 21.25% in FY26.<\/p>\n<p>In the June 2026 quarter, revenue rose 77.60% to Rs 2,719.11 crore and net profit grew 5.37% to Rs 207.27 crore. The share price has gained 225.59% over five years. Domestic institutions raised their holding from 7.76% in September 2025 to 10.68% in September 2026. The stock trades at a PE of 42.44 against an industry PE of 60.75, below the sector average, with a return on equity of 17.76%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_Return_on_Equity_of_2013\"><\/span><strong>Dr Lal PathLabs: Return on Equity of 20.13%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Lal PathLabs is one of India&#8217;s leading diagnostic chains, running laboratories and collection centres across the country. It reported FY26 revenue of Rs 2,864.18 crore, up 12.11% year on year, and net profit of Rs 509.75 crore, up 3.56%. Net profit has compounded at 9.83% a year since FY22, while revenue has grown 7.56% a year. Operating margin was 30.90% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 59.32 against an industry PE of 60.75, below the sector average, with a return on equity of 20.13%. In the June 2026 quarter, revenue rose 18.87% to Rs 829.60 crore and net profit grew 27.24% to Rs 170.50 crore. The share price is up 19.11% over the past year. Domestic institutions raised their holding from 17.91% in June 2025 to 21.59% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stocks_Priced_Between_Rs_1000_and_2000_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Stocks Priced Between Rs 1,000 and 2,000: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these stocks priced between Rs 1,000 and 2,000. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Coforge<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16,475.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,674.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.63%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.26%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.72%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Uno Minda<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19,692.02<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,284.06<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">38.65%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Narayana Health<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7,996.25<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">810.46<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">43.43%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.06%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.75%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Dr Lal PathLabs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,864.18<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">509.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.11%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.03%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these stocks priced between Rs 1,000 and 2,000<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Coforge_Uno_Minda_Narayana_Health_and_Dr_Lal_PathLabs\"><\/span><strong>Institutional Holding in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these stocks priced between Rs 1,000 and 2,000 alongside the promoter. The table uses the latest reported quarter for each. Coforge has the deepest institutional backing, with FII and DII together holding 66.93% as of June 2026. Domestic institutions increased their holding over the past year in Uno Minda (from 15.85% to 17.53%), Narayana Health (from 7.76% to 10.68%) and Dr Lal PathLabs (from 17.91% to 21.59%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Coforge<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Nil<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">33.07%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Uno Minda<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Narayana Health<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">63.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.01%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.04%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Dr Lal PathLabs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">53.19%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.86%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Stocks_Priced_Between_Rs_1000_and_2000\"><\/span><strong>Risks to Weigh in Stocks Priced Between Rs 1,000 and 2,000<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with stocks priced between Rs 1,000 and 2,000 means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Coforge trades at a PE of 47.07 against an industry PE of 17.66, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Stocks_Priced_Between_Rs_1000_and_2000\"><\/span><strong>How to Choose Between Stocks Priced Between Rs 1,000 and 2,000<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from stocks priced between Rs 1,000 and 2,000 comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (17.66 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among stocks priced between Rs 1,000 and 2,000, Coforge stands out for the strongest latest-quarter profit growth at 49.19%, Uno Minda for the fastest profit growth, 38.65% a year since FY22, Narayana Health for the biggest five-year price gain at 225.59% and Dr Lal PathLabs for the highest return on equity at 20.13%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks priced between Rs 1,000 and 2,000 should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Stocks_Priced_Between_Rs_1000_and_2000_to_Watch\"><\/span><strong>Frequently Asked Questions on Stocks Priced Between Rs 1,000 and 2,000 to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_stocks_priced_between_Rs_1000_and_2000_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs are the 4 names this list highlights, with market caps of Rs 90,385 crore, Rs 65,032 crore, Rs 34,664 crore and Rs 32,408 crore respectively. Coforge is notable for the strongest latest-quarter profit growth at 49.19%. Uno Minda stands out for the fastest profit growth, 38.65% a year since FY22. Narayana Health offers the biggest five-year price gain at 225.59%. Dr Lal PathLabs brings the highest return on equity at 20.13%. These are watchlist names for stocks priced between Rs 1,000 and 2,000, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Dr_Lal_PathLabs_a_good_stock_for_long-term_investors\"><\/span><strong>Is Dr Lal PathLabs a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dr Lal PathLabs has a return on equity of 20.13%, a PE of 59.32 against an industry PE of 60.75 and a market cap of Rs 32,408 crore. Net profit has compounded at 9.83% a year since FY22, and FY26 revenue rose 12.11% while June 2026 quarter net profit grew 27.24%. Long-term returns in stocks priced between Rs 1,000 and 2,000 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Uno_Minda_become_a_multibagger_from_here\"><\/span><strong>Can Uno Minda become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks priced between Rs 1,000 and 2,000 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 50.38 against an industry PE of 37.22, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Coforge_Uno_Minda_Narayana_Health_and_Dr_Lal_PathLabs\"><\/span><strong>What is the market cap of Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 27 October 2026, Coforge has a market cap of Rs 90,385 crore, Uno Minda has a market cap of Rs 65,032 crore, Narayana Health has a market cap of Rs 34,664 crore and Dr Lal PathLabs has a market cap of Rs 32,408 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks priced between Rs 1,000 and 2,000.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_stocks_priced_between_Rs_1000_and_2000\"><\/span><strong>What are the risks of investing in stocks priced between Rs 1,000 and 2,000?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 47.07 against an industry PE of 17.66, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Coforge_trading_at_a_PE_of_4707\"><\/span><strong>Why is Coforge trading at a PE of 47.07?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Coforge&#8217;s PE of 47.07 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in stocks priced between Rs 1,000 and 2,000 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Coforge_Uno_Minda_Narayana_Health_and_Dr_Lal_PathLabs\"><\/span><strong>How much do institutions hold in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 25.68% of Uno Minda (8.15% and 17.53%), 19.69% of Narayana Health (9.01% and 10.68%) and 38.95% of Dr Lal PathLabs (17.36% and 21.59%). Rising institutional holding is a useful signal in stocks priced between Rs 1,000 and 2,000, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs are the 4 names this list highlights, with market caps of Rs 90,385 crore, Rs 65,032 crore, Rs 34,664 crore and Rs 32,408 crore respectively. Coforge is notable for the strongest latest-quarter profit growth at 49.19%. Uno Minda stands out for the fastest profit growth, 38.65% a year since FY22. Narayana Health offers the biggest five-year price gain at 225.59%. Dr Lal PathLabs brings the highest return on equity at 20.13%. These are watchlist names for stocks priced between Rs 1,000 and 2,000, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Dr Lal PathLabs a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dr Lal PathLabs has a return on equity of 20.13%, a PE of 59.32 against an industry PE of 60.75 and a market cap of Rs 32,408 crore. Net profit has compounded at 9.83% a year since FY22, and FY26 revenue rose 12.11% while June 2026 quarter net profit grew 27.24%. Long-term returns in stocks priced between Rs 1,000 and 2,000 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Uno Minda become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks priced between Rs 1,000 and 2,000 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 50.38 against an industry PE of 37.22, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 27 October 2026, Coforge has a market cap of Rs 90,385 crore, Uno Minda has a market cap of Rs 65,032 crore, Narayana Health has a market cap of Rs 34,664 crore and Dr Lal PathLabs has a market cap of Rs 32,408 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks priced between Rs 1,000 and 2,000.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in stocks priced between Rs 1,000 and 2,000?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 47.07 against an industry PE of 17.66, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Coforge trading at a PE of 47.07?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Coforge's PE of 47.07 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in stocks priced between Rs 1,000 and 2,000 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 25.68% of Uno Minda (8.15% and 17.53%), 19.69% of Narayana Health (9.01% and 10.68%) and 38.95% of Dr Lal PathLabs (17.36% and 21.59%). Rising institutional holding is a useful signal in stocks priced between Rs 1,000 and 2,000, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap stocks priced between Rs 1,000 and 2,000 compared on market cap, PE, ROE, growth and institutional holding: Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs.<\/p>\n","protected":false},"author":33,"featured_media":329443,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13258,16949,13259,16948],"class_list":["post-329444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-13258","tag-000-and-2","tag-000-sector","tag-stocks-priced-between-rs-1"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["329443"],"rank_math_title":["Stocks Priced Between Rs 1,000 and 2,000 2026: Coforge, Uno Minda"],"rank_math_description":["Stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential: Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs. Compare PE, ROE and growth."],"rank_math_focus_keyword":["stocks priced between Rs 1,000 and 2,000"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-stocks-priced-between-rs-1-000-and-2-000-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=329444"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329444\/revisions"}],"predecessor-version":[{"id":329445,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329444\/revisions\/329445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/329443"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=329444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=329444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=329444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}